Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Flexner

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The Western Journal of Medicine|July 1, 1985
Internal medicine: cyclosporine-a powerful new immunosuppressantC Flexner, M G Perlroth
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Complications of HIV therapyC Flexner, J G Bartlett
Nature|November 19, 1987
Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expressionC Flexner, A Hügin, B Moss
Cellular Immunology|December 1, 1993
Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responsesA W Hügin, C Flexner, B Moss
Clinical Pharmacology and Therapeutics|February 7, 2008
Herbal remedies in resource-poor settings: friend or foe?K E Dooley, C Flexner, A S Andrade
Vaccine|April 1, 1988
Roles of vaccinia virus in the development of new vaccinesB Moss, T R Fuerst, C Flexner, et al.
Vaccine|February 1, 1990
Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2C Flexner, B Moss, W T London, et al.
The Journal of Biological Chemistry|October 6, 2000
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitorsP Dowell, C Flexner, P O Kwiterovich, et al.
Virology|October 1, 1988
Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia virusesC Flexner, S S Broyles, P Earl, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1977
Prostaglandin and histamine involvement in the gastric vasodilator action of pentagastrinJ F Gerkens, C Flexner, J A Oates, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The Western Journal of Medicine|July 1, 1985
Internal medicine: cyclosporine-a powerful new immunosuppressantC Flexner, M G Perlroth
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Complications of HIV therapyC Flexner, J G Bartlett
Nature|November 19, 1987
Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expressionC Flexner, A Hügin, B Moss
Cellular Immunology|December 1, 1993
Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responsesA W Hügin, C Flexner, B Moss
Clinical Pharmacology and Therapeutics|February 7, 2008
Herbal remedies in resource-poor settings: friend or foe?K E Dooley, C Flexner, A S Andrade
Vaccine|April 1, 1988
Roles of vaccinia virus in the development of new vaccinesB Moss, T R Fuerst, C Flexner, et al.
Vaccine|February 1, 1990
Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2C Flexner, B Moss, W T London, et al.
The Journal of Biological Chemistry|October 6, 2000
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitorsP Dowell, C Flexner, P O Kwiterovich, et al.
Virology|October 1, 1988
Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia virusesC Flexner, S S Broyles, P Earl, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1977
Prostaglandin and histamine involvement in the gastric vasodilator action of pentagastrinJ F Gerkens, C Flexner, J A Oates, et al.
Pageof 7